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Abstract We analyzed the functional outcome and
self-evaluation of the voice of patients with T1 glottic
carcinoma treated with endoscopic laser surgery and radio-
therapy. We performed an objective voice evaluation, as
well as a physical, emotional and functional well being
assessment of 19 patients treated with laser surgery and
18 patients treated with radiotherapy. Voice quality is
aVected both by surgery and radiotherapy. Voice parame-
ters only show diVerences in the maximum phonation
time between both treatments. Results in the Voice Hand-
icap Index show that radiotherapy has less eVect on
patient voice quality perception. There is a reduced
impact on the patient’s perception of voice quality after
radiotherapy, despite there being no signiWcant diVer-
ences in vocal quality between radiotherapy and laser
cordectomy.
Keywords Glottic carcinoma · Laser · Voice Handicap 
Index · Cordectomy · Radiotherapy
Introduction
Surgery and radiotherapy oVer the same results in the treat-
ment of early glottic carcinoma, with a cure rate of approx-
imately 90% [1].
The introduction of endoscopic CO2 laser surgery in
early glottic carcinoma (epidermoid carcinoma conWned to
the true vocal cords with normal mobility) has added con-
troversy to the standard treatment choice. Laser surgery is
quicker, which reduces cost considerably. However many
institutions prefer to use radiotherapy in the belief that the
voice will be better preserved after treatment [2]. Although
the principal objective of oncology treatment is the com-
plete eradication of the illness, normal voice preservation is
another important consideration in the treatment choice of
early glottic carcinoma. For this reason, post-treatment
voice quality is a relevant factor to take into account when
evaluating the results.
Quantitative acoustic measurements are more regularly
studied. These are obtained from tools that digitize and ana-
lyze the voice being investigated and quantify the charac-
teristics that deviate from normality, understanding
normality to mean when the voice is uniform in both ampli-
tude and tone periodicity. The addition of noise to the voice
signal is also a defect that aVects voice quality, and this is
the third acoustic characteristic that is studied using spec-
trography.
Another of the factors to take into account is the auditive
perception that is generated in the listener and is evaluated
by ways of perceived voice quality, making use of semi-
objective scales such as the GRBAS scale, as described by
Hirano [3]. It is recommended that these measurements are
made by two experts, although the parameters have shown
suYcient reliability (inter- and intra-observer reproducibil-
ity) when used in a clinical setting [4].
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Although all these measurements are important parame-
ters in deWning voice quality, they fail to provide informa-
tion on the patient’s perceived voice quality. For this there
is a method available that permits the patient to describe the
sensations their voice gives: the Voice Handicap Index [5].
It is a questionnaire that reviews situations grouped into
three areas (functional, physiological and emotional) and
gives an idea of the subjective impact that a vocal problem
produces in a speciWc individual.
In this study, we present the objective and subjective
analysis of voice quality following treatment of an early
epidermoid glottic carcinoma. Results from the objective
evaluation of the voice, along with the self-evaluation of
voice quality quantiWed using the Voice Handicap Index of
a group of patients treated with endoscopic laser surgery
are compared with patients treated with radiotherapy.
Materials and methods
Voice analysis and quality of life studies of 19 patients
treated with laser surgery and 18 with radiotherapy, suVer-
ing from early glottic carcinoma, were evaluated. Lesions
were classiWed according to the American Joint Committee
on Cancer [6].
In patients who received radiotherapy as the primary
treatment, this was performed using a 6 mv linear accelera-
tor to bilateral ports and one in front, with Weld sizes rang-
ing from 5 £ 5 to 6 £ 6 cm. Wedges were used to establish
dose homogeneity.
In the case of patients treated with surgery, the treatment
consisted of direct laryngoscopy for the complete resection
(partial transmuscular cordectomy) of the lesion with CO2
laser. Objective voice analysis and voice quality studies,
performed by both patients and examiners by means of an
examination protocol including: perceptual analysis of dys-
phonia, acoustic analysis, aerodynamic eYciency and
patient perception, were applied to both groups. In all
patients, this protocol was undertaken at least 6 months
after completing treatment.
Perceptual analysis of dysphonia (GRBAS)
Perceptual analysis of dysphonia was performed using the
GRBAS scale [3]. Two experienced professionals evalu-
ated the recorded voice samples simultaneously, classifying
each sample from 0 to 3 (0 = normal, 1 = mild,
2 = moderate, 3 = severe). The severity of hoarseness is
quantiWed under the parameter G (grade), which represents
overall voice quality. B (breathiness): audible impression of
turbulent air leakage through an insuYcient glottic closure,
which may include short aphonic moments (unvoiced seg-
ments). R (roughness or harshness): audible impression of
irregular glottic pulses, abnormal Xuctuations in F0, sepa-
rately perceived acoustic impulses (as in vocal fry),
includes diplophonia and register breaks. A (asthenicity):
impression of weakness in the spontaneous phonation,
hypokinetic or hypofunctional voice. S (strain, vocal ten-
sion): auditive impression of excessive force or tension
associated with spontaneous phonation.
Acoustic and spectrographic analysis
The acoustic analysis was performed using Doctor Speech
V3 software for Windows 95. The acoustic signal was
recorded using the Voice Assessment application. The com-
puter used was a Pentium II at 100 MHz and with 16 Mb of
RAM and a Sound Blaster 16 sound card. The sampling
frequency was 44,100 Hz and a high frequency range
microphone was used. The microphone was located 10 cm
from the patient’s mouth while they emitted the “e” sound
at comfortable intensity and pitch levels in a soundproof
chamber. The computer captured 3 s of sound. Once the
signal was digitized, the computer calculated the following
acoustic parameters: fundamental frequency (F0), jitter or
frequency variation (%), shimmer or amplitude variation
(%) and NNE or normalized noise energy, which measures
the degree of noise produced by turbulent air escaping
through the glottis during vocal emission.
Using the same digitized voice sample, a narrow band
spectrogram was generated (45 Hz) using the Speech Anal-
ysis application. The spectrograms obtained were grouped
into four types according to the Yanagihara criteria [7].
Aerodynamic eYciency analysis
This consisted in measuring the maximum phonation time
(TMF) for the “a” vocal after instructing the patient to sus-
tain this vocal for the longest time possible at a comfortable
pitch and intensity. The patients were asked to repeat the
test at least three times and the highest value was retained.
Patient self-perception analysis (Voice Handicap Index)
The patients completed the “Voice Handicap Index” via a
self-evaluation form comprising 30 questions covering
three domains [5]: functional, physical and emotional,
translated from the original work in English by one of the
authors. Each question was assigned a score of 0–4 (from
least disability to most). In each item, the maximum score
was 40 points and we classiWed them as mild disability (less
than 20), moderate (21–30) and severe (more that 30). Add-
ing the three scores together, the maximum possible was
120, and we classiWed the vocal disability as mild (less than
30), moderate (31–60), severe (61–90) and very severe
(91–120).Eur Arch Otorhinolaryngol (2008) 265:543–548  545
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Statistical analysis
The data obtained was gathered in the statistical database
SPSS 12.0. The statistical analysis used was the Student’s t
test in order to compare averages and the Chi-squared test
for comparing proportions. The statistical diVerences were
considered signiWcant when P was lower than 0.05.
Results
In the patient group treated with CO2 laser, the ages were in
the range 44–86 years, with an average age of 64 and a
mean follow-up of 30 months (12–48). In the patient group
treated with radiotherapy, the ages were in the range 55–
81 years, with an average age of 67 and a mean follow-up
of 43 months (6–81). All patients in both groups were
males.
In both groups, all lesions corresponded to stage I of the
TNM classiWcation. In the group of 19 patients treated with
surgery, all the lesions were qualiWed as T1a and in the case
of the 18 radiotherapy patients, 13 were classiWed as T1a
and 5 as T1b. No metastases in the neck, or distant, were
detected. At the time of the study, all patients were free
from illness.
In the group of patients treated with radiotherapy, the
nominal total dose was 6,525 cGy, with 225 cGy daily
doses for a total of 29 days. Of the PTV volume, 100%
received minimum doses of approximately 5,700 cGy, a
maximum dose of approximately 6,720 cGy and an average
dose of 6,520 cGy.
Aerodynamic eYciency and spectrographic analysis
In Table 1, the maximum phonation times are presented for
the “a” vocal along with the quantitative voice analysis of
the vocal “e” obtained in the groups treated with laser and
with radiotherapy. There was no signiWcant diVerence
between the parameters: fundamental frequency, (F0), jitter,
shimmer and NNE on comparing both groups. However,
there were signiWcant diVerences in the maximum phonation
time.
In spectrographic terms, the 19 voice samples of patients
treated with laser were classiWed as Grade I 4 (21%), Grade
II 5 (25%), Grade III 7 (37%) and Grade IV 3 (15%). In the
group of patients treated with radiotherapy, the 18 voice
samples were classiWed as Grade I 1 (5%), Grade II 7
(39%), Grade III 5 (28%) and Grade IV 5 (28%). On com-
paring the spectrograms obtained in both groups, there were
no statistically signiWcant diVerences (P =0 . 4 0 1 ) .
Perceptual dysphonia analysis (GRBAS)
Table 2 shows the results obtained using GRBAS scale on
patients treated with CO2 laser surgery. Mild dysphonia
was found in 31.5% of the cases, moderate dysphonia in
37% and severe dysphonias in the remaining 31.5%.
Table 3 shows the GRABS results of the patients treated
with radiotherapy. Normal voices were observed in 11%,
mild dysphonias in 44.4%, moderate dysphonia in 27.8%
and severe dysphonia in 16.7% of the cases. On comparing
the results obtained in the G domain of the GRABS scale,
which corresponds with the degree of dysphonia, no signiW-
cant diVerence was found between each group (P = 0.309).
Patients self-perception analysis (Voice Handicap Index)
Table 4 shows the averages obtained from the “Voice
Handicap Index” questionnaire in the functional, physical
and emotional scales, as well as the scores obtained in both
Table 1 MPT and acoustic analysis of the vocal /e/ after treatment:
laser (n = 19) or radiotherapy (n =1 8 )
MPT maximum phonation time, F0 (Hz) fundamental frequency, NNE
normalized noise energy
Variable Laser Radiotherapy
MPT 11.83 § 5.28 8.63 § 3.23 P <0 . 0 5
F0 (Hz) 173.39 § 47.41 199.04 § 51.46 NS
Jitter (%) 0.44 § 0.24 0.72 § 0.91 NS
Shimmer (%) 5.08 § 4.72 4.07 § 4.04 NS
NNE (dB) ¡5.82 § 2.98 ¡5.02 § 4.44 NS
Table 2 Results obtained using GRBAS scale on the patients treated
with CO2 laser surgery (n =1 9 )
G grade, R roughness, A asthenicity, B breathiness, S strain
012 3 T o t a l
G 0% 31.5% (6) 37% (7) 31.5 (6) 100% (19)
R 10.5% (2) 58% (11) 26% (5) 5.5% (1) 100% (19)
A 21% (4) 42% (8) 21% (4) 16% (3) 100% (19)
B 84% (16) 16% (3) 0% 0% 100% (19)
S 31.5% (6) 31.5% (6) 21% (4) 16% (3) 100% (19)
Table 3 GRABS results of patients treated with radiotherapy (n = 18)
G grade, R roughness, A asthenicity, B breathiness, S strain
0 123 T o t a l
G 11.1% (2) 44.4% (8) 27.8% (5) 16.7%(3) 100% (18)
R 55.6% (10) 33.3% (6) 5.6% (1) 5.6% (1) 100% (18)
A 55.6% (10) 33.3% (6) 11.1% (2) 0% 100% (18)
B 44.4% (8) 27.8% (5) 22.2% (4) 5.6% (1) 100% (18)
S 77.8% (14) 16.7% (3) 5.6% (1) 0% 100% (18)546 Eur Arch Otorhinolaryngol (2008) 265:543–548
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groups. Upon completing the comparison between the two
groups, the statistical diVerence is signiWcant, in favor of
the radiotherapy patients in the functional and emotional
ratings as well as the global scores. No signiWcant diVer-
ences were found in the physical scales.
Discussion
Early glottic carcinoma can be treated using endoscopic
surgery, radiotherapy or partial open surgery. Lesions lim-
ited to the vocal fold are normally treated with endoscopic
surgery or partial open surgery, with local control results of
between 80 and 90% [8]. In choosing one treatment or
another, one should contemplate the cure rate, larynx pres-
ervation rate, post-treatment voice quality, morbidity and
treatment cost [9].
In recent years, endoscopic CO2 laser surgery has made
headway compared to radiotherapy, based on its good
oncology results and reduced morbidity. CO2 laser treat-
ment in early glottic carcinoma has greatly improved voice
quality compared to that obtained following cordectomy
via laryngoWssure. as documented by some authors such as
Keilmann et al. [10]. However in other published studies,
such as Schindler [11], this improvement is not as evident.
One of the advantages of laser surgery is its low cost when
compared to radiotherapy, as well as the additional beneWt
of being able to opt for radiotherapy at a later stage to treat
a relapse or second primary malignancy. In many institu-
tions, these tumours are treated with external radiotherapy
because of the supposedly better functional and quality of
life results obtained compared to patients treated with sur-
gery [12].
Various studies have been published comparing voice
quality after both treatments [13–15]. In some studies, voice
quality is similar, while other authors maintain that the voice
is better after radiotherapy than after laser surgery [16–18].
However, there are fewer published works that include
patient opinions with regard to the impact the illness and the
treatment has had on their quality of life [19–21].
In our work, no signiWcant diVerences in fundamental
frequency (F0), jitter, shimmer and NNE were found
between the two groups. There were, however, signiWcant
diVerences in maximum phonation time, favoring the
patients treated with CO2 laser cordectomy. Other authors
do not Wnd signiWcant diVerences in the maximum phona-
tion time between the groups [22–24]. In the study by Tam-
ura et al. [13] the fundamental frequency is higher for
patients treated with CO2 laser surgery, which suggests that
this surgery has a greater impact on the vocal fold function
than radiotherapy. Krengli et al. [18] found statistically sig-
niWcant diVerences in the vocal acoustic parameters and
fundamental frequency, favoring radiotherapy patients.
In terms of the spectrograms obtained in both groups, no
statistically signiWcant diVerences were found. According
to our results, 48% of patients treated with laser, and 44%
of radiotherapy patients have an aesthetically acceptable
voice (type I and II dysphonia).
There were no signiWcant diVerences found between the
two groups on comparing the scores obtained using the G
parameter of the GRABS scale, which corresponds to the
degree of dysphonia. Other studies such as Loughran et al.
[20] failed to Wnd statistically signiWcant diVerences on
comparing GRABS between patients treated with each
technique. In our work, there is an elevated percentage of
patients treated with CO2 laser (84%) who obtained low
scores in the breathy voice domain (B), which shows that
apart from individual healing patterns, or treatment-induced
secondary glottic defects, post-cordectomy phonetic com-
pensating mechanisms are important in determining new
voice quality. According to Sittel et al. [25], glottic phona-
tion voice quality is better than that obtained by the non-
glottic phonation. Although one could believe that these
patients had beneWted from voice therapy, there are contra-
dictory opinions on this [26].
While acoustic, physiological and perceptual measure-
ments are important parameters in assessing vocal function,
they do not provide information about the patient’s percep-
tion of their own voice quality. Given that voice quality,
because of its potential impact on quality of life, can be an
important factor in the choice of treatment, it is important
to include this information when evaluating results. Not
only should dysphonia as a by-product of laryngeal physi-
ology be considered, but also the eVects on patient quality
of life must be considered as well.
In our study, in order to quantify patient opinion as to the
impact caused by treatment, the Voice Handicap Index has
been employed. This is an instrument developed to help the
professional in deciding the therapy, taking into account the
patient’s subjective sensations with respect to their prob-
lem. It is a post-treatment global result evaluation method,
from the point of view of the patient’s perceived global
well being (physical, mental and social). Although it is a
subjective evaluation based on the patient’s own percep-
tion, it can provide valuable data as to the reasons why
Table 4 Averages obtained from the “Voice Handicap Index” ques-
tionnaire in the functional, physical and emotional scales, as well as the
scores obtained in both groups
Laser Radiotherapy
Functional 11.47 (0–32) 2.83 (0–17) P <0 . 0 5
Physical 12.68 (0–31) 6.22 (0–18) NS
Emotional 4.63 (0–20) 0.61 (0–5) P <0 . 0 5
Global 28.79 (0–77) 9.67 (0–29) P <0 . 0 5Eur Arch Otorhinolaryngol (2008) 265:543–548  547
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patients with similar dysphonia characteristics can have
diVerent handicap severity indices [27]. VHI allows investi-
gators to obtain information regarding the patient’s subjec-
tive perception as well as providing the physician with
important information pre and post treatment. Given that
the preservation of adequate phonation is an important con-
sideration in early glottic carcinoma treatment selection and
given equal oncologic results between the two treatments,
the VHI proves to be a very important tool in the therapeu-
tic decision-making process.
In our study, low scores were obtained for both groups in
the three scales, functional, physical and emotional. This
could imply reduced impact in the quality of life of patients
treated either with laser surgery or radiotherapy. The statisti-
cally signiWcant diVerences are in favor of radiotherapy
patients in the functional and emotional scales, as well as the
global scores. Although acoustic and perceptual voice analy-
sis in both groups showed no signiWcant diVerences, the radio-
therapy group scored less in the VHI than the surgical group.
Loughran et al. [20] performed a study where they com-
pared the results between both therapies in terms of the
Voice Handicap Index as well as two other questionnaires
aimed at evaluating the patient’s subjective voice quality
(Vocal Performance Questionnaire, VPQ, and Voice Symp-
tom Score, VoiSS). In this work, no signiWcant diVerences
were discovered between radiotherapy and CO2 laser sur-
gery patients in any of the questionnaires, except for the
emotional sub-scale inVoiSS.
However, in other studies the average global score in the
Voice Handicap Index questionnaire is lower for patients
treated with endoscopic laser resection than in patients
treated with radiotherapy. Peeters et al. [21] compared the
results of both the Voice Handicap Index and a quality of
life questionnaire (COOP/WOONCA) following both treat-
ments. In their results, they found statistically signiWcant
diVerences in favor of laser surgery for the VHI and none in
the quality of life results. They found higher scores for glo-
bal VHI results in 40% of patients treated using surgery,
and 58% for those treated with radiotherapy. Their conclu-
sions reveal that the treatment for T1 glottic carcinoma fre-
quently generates vocal problems in day-to-day life,
inXuencing negatively certain social activities. This data
contradicts the results of our study where VHI scores of
both groups were low and the diVerences found favored the
radiotherapy patient group. Recently, Cohen et al. [28] pub-
lished a meta-analysis in order to classify the quality of life
related to voice in patients with TI glottic carcinomas
treated with radiotherapy compared with CO2 laser resec-
tion. Six studies with a total of 208 patients treated with
surgery and 91 with radiotherapy had similar scores for
VHI, from which they concluded that both treatments result
in comparable vocal handicap levels for patients with T1
glottic carcinomas [28].
In other works such as that by Stoeckli [19], which value
long-term results with regard to quality of life (QOL) of
early glottic carcinoma patients, no diVerences were found
between the two treatments and they conclude that both
therapies provide good results in terms of quality of life.
They show in addition, diVerences in the relative scores for
questions such as swallowing, xerostomy and dental prob-
lems, favoring patients treated surgically, and show no
diVerences with regard to perceived voice quality. These
results could be related to the fact that xerostomy, edema,
mucositis and Wbrosis increase the sensation of handicap to
such an extent that these eVects on patient quality of life
could be greater than those coming from the dysphonia
itself in laser surgery patients.
Few are the patients that have a so-called “normal” voice
upon completing radiotherapy, above all taking into account
that the larynx of these patients has undergone a surgical
procedure in order to get a biopsy, has been intensely
exposed to tobacco smoke and belongs generally to aged
patients. All these factors negatively aVect voice quality
[29]. Despite this, the results of our work reveal that radio-
therapy treatment for T1 glottic carcinoma generates lower
repercussions in the subjective perception of residual dys-
phonia, as much in functional as in emotional aspects, when
compared with CO2 laser surgery. The scores obtained in the
VHI were low in the three domains for both groups, from
which we can infer a scarce impact on the quality of life for
laser surgery and radiotherapy for this type of patient.
Conclusions
Both CO2 laser resection and external radiotherapy as treat-
ment for T1 vocal carcinoma oVer similar objective mea-
surement results (acoustic and spectrographic analysis) and
subjective measurement results (GRABS scoring). How-
ever, in our series, the self-evaluation of the quality of
voice, quantiWed by the VHI, shows a lower impact for
radiotherapy patients.
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